一个激活AKT2和人类低血糖的突变
概括
一种新的AKT2基因突变导致儿童严重的禁食低血糖和生长问题. 这一发现将构成性信号通路激活与全身代谢疾病联系起来,为罕见的遗传疾病提供了新的见解.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 儿科内分泌学 儿科内分泌学
背景情况:
- 病理性禁食低血糖症通常是由过量的胰岛素或影响葡萄糖生产的代谢障碍引起的.
- 无法解释的重复性严重低血糖症和儿童不对称的生长促使进一步调查.
研究的目的:
- 为了调查三个不相关的儿童与不对称的成长不解释的禁食低血糖的遗传基础.
- 阐明所观察到的代谢和生长异常背后的分子机制.
主要方法:
- 基因分析以确定AKT2基因中的突变.
- 在异质细胞中进行功能性研究,以评估发现的突变对AKT2信号传递的影响.
- 临床评估受影响的儿童,包括低血糖和生长模式的评估.
主要成果:
- 这三个孩子都在氨酸/氨酸激酶AKT2基因中具有共同的新突变,p.Glu17Lys.
- 突变的AKT2蛋白显示出对血的构成性招募,导致胰岛素独立的下游信号传递.
- 这种分子缺陷解释了观察到的严重禁食低血糖症和不对称的生长.
结论:
- 正如AKT2突变所示,信号通路的构成性,细胞自主激活可以导致全身代谢疾病.
- 这些发现扩大了对病理性禁食低血糖症遗传原因的理解.
- 这项研究突出了AKT2信号在葡萄糖平衡和生长调节中的作用.
更多相关视频
08:47Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
